KOCAA
BSX icon

Knights of Columbus Asset Advisors’s Boston Scientific BSX Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-25,967
Closed -$1.63M – 393
2026
Q1 		$1.63M Buy
25,967
+2,809
+12% +$225K 0.09% 216
2025
Q4 		$2.21M Sell
23,158
-44,543
-66% -$4.37M 0.13% 176
2025
Q3 		$6.61M Sell
67,701
-1,161
-2% -$120K 0.38% 73
2025
Q2 		$7.4M Buy
68,862
+5,188
+8% +$525K 0.45% 62
2025
Q1 		$6.42M Sell
63,674
-23,577
-27% -$2.37M 0.44% 66
2024
Q4 		$7.79M Sell
87,251
-131
-0.1% -$11.5K 0.51% 52
2024
Q3 		$7.32M Sell
87,382
-60,186
-41% -$4.74M 0.48% 61
2024
Q2 		$11.4M Sell
147,568
-31,625
-18% -$2.31M 0.74% 25
2024
Q1 		$12.3M Buy
179,193
+14,872
+9% +$956K 0.89% 19
2023
Q4 		$9.5M Buy
164,321
+2,388
+1% +$127K 0.61% 27
2023
Q3 		$8.55M Buy
161,933
+8,716
+6% +$457K 0.78% 20
2023
Q2 		$8.29M Buy
153,217
+2,194
+1% +$115K 0.74% 19
2023
Q1 		$7.56M Buy
151,023
+90,107
+148% +$4.25M 0.74% 20
2022
Q4 		$2.82M Buy
+60,916
New +$2.64M 0.29% 111
2020
Q2 		– Sell
-42,430
Closed -$1.38M – 333
2020
Q1 		$1.38M Buy
42,430
+2,000
+5% +$78.1K 0.17% 181
2019
Q4 		$1.83M Hold
40,430
– – 0.16% 228
2019
Q3 		$1.65M Sell
40,430
-5,300
-12% -$225K 0.63% 62
2019
Q2 		$1.97M Buy
45,730
+5,500
+14% +$212K 0.77% 51
2019
Q1 		$1.54M Sell
40,230
-70
-0.2% -$2.67K 0.62% 61
2018
Q4 		$1.42M Sell
40,300
-300
-0.7% -$10.9K 0.65% 56
2018
Q3 		$1.56M Hold
40,600
– – 0.63% 59
2018
Q2 		$1.33M Sell
40,600
-3,400
-8% -$103K 0.64% 60
2018
Q1 		$1.2M Buy
44,000
+7,900
+22% +$215K 0.55% 69
2017
Q4 		$895K Sell
36,100
-2,500
-6% -$69K 0.58% 68
2017
Q3 		$1.13M Buy
38,600
+18,800
+95% +$519K 0.76% 56
2017
Q2 		$549K Sell
19,800
-4,000
-17% -$106K 0.38% 82
2017
Q1 		$592K Buy
+23,800
New +$579K 0.42% 84

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Knights of Columbus Asset Advisors's BSX Position: Q2 2026 in Review

Knights of Columbus Asset Advisors sold out of Boston Scientific (BSX) in Q2 2026, closing a stake of 25,967 shares — an estimated $1.63M sold.

Knights of Columbus Asset Advisors first reported a position in BSX in Q1 2017 and held it in 27 quarters. The position peaked at $12.3M in Q1 2024. 1,487 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Knights of Columbus Asset Advisors reported no remaining Boston Scientific position as of Q2 2026 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 25,967 Boston Scientific shares in Q2 2026, an estimated $1.63M.
  • Knights of Columbus Asset Advisors first reported a position in Boston Scientific in Q1 2017 and held it in 27 quarters.
  • Knights of Columbus Asset Advisors's Boston Scientific position peaked at $12.3M in Q1 2024.
  • 1,487 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2026, filed 31 Jul 2026.